Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine
Status:
Withdrawn
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to compare the antidepressant effect of lithium versus
placebo in adults receiving ketamine. Lithium is available commercially for depression;
ketamine is available commercially and can help the symptoms of depression; however, it has
not been approved by the U.S. Food and Drug Administration (FDA) for this use. The FDA has
allowed the use of this drug in this research study.